Skip to main content
. Author manuscript; available in PMC: 2013 Nov 25.
Published in final edited form as: Mol Cell Endocrinol. 2012 Aug 30;364(1-2):83–88. doi: 10.1016/j.mce.2012.08.012

Figure 2.

Figure 2

(A) Immunoblot of telomerase protein in cultured human PBMCs treated with ethanol vehicle (control), with 1 M estradiol, or with a combination (PMA/Io) of PMA (phorbol myristate acetate; final concentration 50 ng/ml) and ionomycin (final concentration 1 g/ml). Molecular weight standards are shown at the left. (B) Quantitation of telomerase activity in human PBMCs under control conditions, treated with estradiol (1 M), or stimulated with PMA/Io as above. Telomerase activity is shown as amole of product/min/mg protein.